In this paper we present the room temperature synthesis of a novel serie of 1,4-disubstituted-1,2,3-triazoles 4a-l by employing the (3 + 2) cycloaddition reaction of pyrimidinones containing alkyne functions with different model azides in the presence of copper sulphate and sodium ascorbate. To obtain the final triazoles, we also synthesized the major precursors 6-amino-5-cyano-1,4-disubstituted-2(1H)-pyrimidinones 3a-r from ethyl 2,2-dicyanovinylcarbamate derivatives 2a-c and various primary aromatic amines containing an alkyne group. The triazoles were prepared in good to very good yields.
Introduction
The copper-(I)-catalyzed Huisgen-Sharpless-Meldal 1,3-dipolar cycloaddition between alkynes and azides ('click' chemistry) resulting in the formation of 1,4-disubstituted-1,2,3-triazoles has gained significant importance because of its wide range of applications in various fields of drug discovery [1] , bioconjugation [2] and material or surface science [3, 4] . Amongst the various classes of nitrogen heterocycles, 1,2,3-triazoles and their derivatives deserve special recognition due to their wide usage in industrial applications as dyes, photographic materials, corrosion inhibitors and as herbicidal, fungicidal and antibacterial agrochemicals [5, 6] . Several members of the 1,2,3-triazole family exhibit a broad spectrum of antiinfectious properties such as antimicrobial [7] , anti-HIV [8] , anti-allergic [9] and antimalarial activities [10] . On the other hand, 2(1H)-pyrimidinones also show significant biological activities [11] . For instance, 2(1H)-pyrimidinones derivatives have been screened for antihypertension [12] , insulin-mimetic [13] , anti-inflammatory [14] and anti-proliferative [15] activities or as selective α 1a -andrenergic receptor antagonists [16] . Interested by the wide variety of pharmacological properties and potential applications of both 2(1H)-pyrimidinones and 1,2,3-triazoles we have designed the synthesis of hybrid molecules consisting of both moieties. Our method is based on the (3 + 2) cycloaddition reaction of 6-amino-5-cyano-1-(meta-or para-ethynylphenyl)-4-substituted-2(1H)-pyrimidinones with different azides in the presence of copper sulphate and sodium ascorbate at room temperatures that affords 1,4-disubstituted-1,2,3-triazoles.
Results and Discussion
Ethyl 2,2-dicyanovinylcarbamate derivatives 2a-c were prepared in good yields by action of malononitrile with ethyl N-(ethoxycarbonyl)imidates 1a-c following a previously reported method [17] (Scheme 1). The reaction of these compounds 2a-c with primary aromatic amines in chlorobenzene under reflux yielded the 6-amino-5-cyano-1,4-disubstituted-2(1H)-pyrimidinones 3a-r in yields ranging from 55 to 76% (Table 1) . This synthetic method is more general and easier to implement than the methods already described in the literature [18, 19] . Scheme 1. Synthesis of 6-amino-5-cyano-1,4-disubstituted-2(1H)-pyrimidinones (3a-r). Reagents and conditions: (i) primary aromatic amines, chlorobenzene, 110 °C, (2~4) h. The (3 + 2) cycloaddition of 6-amino-5-cyano-1-(meta-or para-ethynylphenyl)-4-substituted-2(1H)-pyrimidinones 3k, 3l, 3q and 3r with different azides A 1 , A 2 and A 3 ( Figure 1 ) in the presence of Na-ascorbate, THF/t-BuOH/H 2 O and CuSO 4 .5H 2 O, at room temperature resulted in the corresponding 1,4-disubstituted-1,2,3-triazole compounds 4a-l (Scheme 2) in good yields ( Table 2 ). The structures of compounds 3a-r were in accordance with their spectroscopic data. The IR spectra of the compounds in general exhibited an absorption band at 2,210 cm for the compounds 3e, 3f, 3k, 3l, 3q and 3r indicated that the terminal alkyne C≡C-H was present in these compounds. H-NMR spectra the most significant information was the disappearance of triplet and quadruplet of ethoxy groups present in the starting reagent 2a-c and the appearance of signals for the protons of the group R 2 introduced by the primary aromatic amines.
Structures of compounds 4a-l were established on the basis of their spectroscopic data. The IR absorption band corresponding to a terminal C≡C-H group was not observed around 3,271 cm H-NMR spectra of the 'click' products the terminal triple bonded proton signal (δH = 4.3 ppm) of the alkynes 3 disappeared and the newly formed triazole signal was observed at 8.5-9.5 ppm. The triazole ring formation was also identified from the 13 C-NMR spectra with the new signals of the ethylenic C atoms of the 1,2,3-triazole moiety at δ = 120-122 ppm (CH ar-triazole ) and δ = 146-148 ppm (C q-triazole ).
X-ray crystal analysis of compounds 3b and 3g
To further confirm the structure of compounds 3, an X-ray crystallographic study of compounds 3b and 3g was carried out (Figures 2 and 3 ). Crystals were obtained by slow evaporation from methanol solution. Crystallographic data were collected at 180K with an Oxford-Diffraction XCALIBUR CCD Diffractometer equipped with a Cryojet cooler device from Oxford Instruments. Structures were solved by direct methods using SIR92 [20] and refined by full-matrix least-squares procedures on F using the programs of the PC version of CRYSTALS [21] . Atomic scattering factors were taken from the International Tables for X-ray Crystallography [22] . 
Conclusions
In summary, various 6-amino-5-cyano-1-(meta-or para-ethynylphenyl)-4-substituted-2(1H)-pyrimidinones were synthesized and utilized as starting materials in the 'click' reaction to attach azido residues. Consequently, we have employed these, in house synthesized precursors, to prepare a new class of hybrid molecules 1,4-disubstituted-1,2,3-triazoles employing already known chemistry of (3 + 2) cycloaddition of azides and acetylenes in good to very good yields. All products that we have obtained were hitherto unknown. A number of them are presently under pharmacological screening.
Experimental
Commercially available reagent grade chemicals were used as received without additional purification. All reactions were followed by TLC (E. Merck Kieselgel 60 F-254), with detection by UV light at 254 nm. Column chromatography was performed on silica gel (60-200 mesh E. Merck). IR spectra were recorded on a Perkin-Elmer PARAGON 1000 FT-IR spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane (0 ppm) as internal reference and the following multiplicity abbreviations were used: s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet; J in hertz. The mass spectra were recorded on an ion trap mass spectrometer (Finnigan LCQ Deca XP Max) using electrospray as an ionization source. Melting points were determined on an Electrothermal 9300 capillary melting point apparatus and are uncorrected. UV-visible spectra were recorded on a Specord 205 Analytikjena spectrophotometer. The purity of all compounds was determined by LC-PDA-MS methods and was found to be in the range between 96-99%.
General experimental procedure for preparation of 6-amino-5-cyano-1,4-disubstituted-2(1H)-pyrimidinones 3a-r
To a magnetically stirred solution of the ethyl 2,2-dicyanovinylcarbamate derivatives 2a-c (1 equiv) in chlorobenzene (25 mL), a primary aromatic amine (1.2 equiv) added and reaction mixture was stirred for 2~4 h at 110 °C. Reaction progress was monitored by TLC using the indicated eluents. The resulting mixture was allowed to cool at room temperature. The formed precipitate was isolated by filtration and washed with ethanol or with diethyl ether for 3e, 3f, 3k, 3l, 3q and 3r to give pure products. 
6-Amino-5-cyano-1,4-diphenyl-2(1H)-pyrimidinone (3a)
.
6-Amino-5-cyano-1-(naphthalen-1-yl)-4-phenyl-2(1H)-pyrimidinone (3b)
6-Amino-5-cyano-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-2(1H)-pyrimidinone (3d)
6-Amino-5-cyano-1-(3-ethynylphenyl)-4-phenyl-2(1H)-pyrimidinone (3e)
6-Amino-5-cyano-4-(4-methylphenyl)-1-(3,4,5-trimethoxyphenyl)-2(1H)-pyrimidinone

6-Amino-5-cyano-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-(4-methylphenyl)-2(1H)-pyrimidinone
6-Amino-5-cyano-1-(3-ethynylphenyl)-4-(4-methylphenyl)-2(1H)-pyrimidinone (3k)
6-Amino-5-cyano-1-(4-ethynylphenyl)-4-(4-methylphenyl)-2(1H)-pyrimidinone (3l)
6-Amino-4-benzyl-5-cyano-1-phenyl-2(1H)-pyrimidinone (3m)
6-Amino-4-benzyl-5-cyano-1-(naphthalen-1-yl)-2(1H)-pyrimidinone (3n)
6-Amino-4-benzyl-5-cyano-1-(3,4,5-trimethoxyphenyl)-2(1H)-pyrimidinone (3o)
6-Amino-4-benzyl-5-cyano-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2(1H)-pyrimidinone (3p)
6-Amino-4-benzyl-5-cyano-1-(3-ethynylphenyl)-2(1H)-pyrimidinone (3q)
General experimental procedure for preparation of 1,4-disubstituted-1,2,3-triazoles 4a-l
The mixture of alkyne 3 (1 mmol) and azides (1 mmol) was suspended in a mixture of THF/tBuOH/H 2 O (3:1:1, v/v/v, 6/2/2 mL). Sodium ascorbate (89 mg, 0.45 equiv) was added followed by addition of CuSO 4 5H 2 O (16 mg, 0.1 equiv). The heterogeneous mixture was stirred vigorously for 2 days, at which time TLC showed complete conversion. The reaction mixture was concentrated under vacuum and the residue was treated with H 2 O (50 mL) and extracted with dichloromethane (3 × 15 mL). The combined organic extracts were dried over anhydrous Na 2 SO 4 , filtered and evaporated under reduced pressure to give a crude mass. Column chromatography purification using ethyl acetate/dichloromethane as eluent gave the clicked product 4. cyano-1-(3-(1-(4-(isopropylamino)-6-(methylthio)-1,3,5-triazin-2-yl)-1H-1,2,3 [3,2- 
6-Amino-5-cyano-4-(4-methylphenyl)-1-(3-(1-(phenylthiomethyl)-1H-1,2,3-triazol-4-yl)phenyl)-2(1H)-pyrimidinone (4a)
6-Amino-5-cyano-4-(4-methylphenyl)-1-(4-(1-(phenylthiomethyl)-1H-1,2,3-triazol-4-yl)phenyl)-2(1H)-pyrimidinone (4b
6-Amino-4-benzyl-5-cyano-1-(4-(1-(phenylthiomethyl)-1H-1,2,3-triazol-4-yl)phenyl)-2(1H)-pyrimidinone (4d)
6-Amino-5-cyano-1-(3-(1-(4-(isopropylamino)-6-(methylthio)-1,3,5-triazin-2-yl)-1H-1,2,3-triazol-4-yl)-phenyl)-4-(4-methylphenyl)-2(1H)-pyrimidinone (4e)
6-Amino-5-cyano-1-(4-(1-(4-(isopropylamino)-6-(methylthio)-1,3,5-triazin-2-yl)-1H-1,2,3-triazol-4-yl)-phenyl)-4-(4-methylphenyl)-2(1H)-pyrimidinone (4f
6-Amino-4-benzyl-5-
6-Amino-4-benzyl-5-cyano-1-(4-(1-(4-(isopropylamino)-6-(methylthio)-1,3,5-triazin-2-yl)-1H-1,2,3-triazol-4-yl)phenyl)-2(1H)-pyrimidinone (4h)
(Z)-Ethyl-2-(4-(4-(3-(6-amino-5-cyano-4-(4-methylphenyl)-2-oxopyrimidin-1(2H)-yl)phenyl)-1H-1,2,3-triazol-1-yl)benzylidene)-7-methyl-3-oxo-5-phenyl-3,5-dihydro-2H-thiazolo
